CHEK1 and endometriosis: Interestingly, EMSCs from patients with endometriosis were sensitive to E2 treatment, resulting in a 1.5–2-fold increase in DNA2 mRNA expression and 1.2–2.8-folds increase in CHK1 mRNA levels (Fig. 5a, b).